Dr Beat Bornhauser talks to ecancer at the ALL Assembly 2018 Meeting in Amsterdam about in vitro diagnostic models for ALL and what we can learn on actionable targets.

Dr Bornhauser explains that a co-cultured system can be used where primary leukaemia cells are cultured on top of mesenchymal stroma cell.

He states that library of agents is expanding all the time and that he would like to look at the correlation of activity of agents with effects on the platform.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.